PDCD1 and neoplasm: demonstrated that PD-1 ablation assists emergency myelopoiesis and differentiation of effector myeloid cells to strengthen anti-tumor immunity by increasing intermediates of glycolysis, tricarboxylic acid cycle (TCA cycle), pentose phosphate pathway (PPP) and elevated cholesterol (39).